Pharmacy Benefits Management Services Home

Cases of venous and arterial thrombosis or thromboembolism and retinal artery and retinal vein occlusions have been reported with TXA. Thromboembolic risk: Review of US post-marketing reports of venous and arterial thrombotic events in women on oral TXA led to revised warnings and precautions in the product label in April 2011. ................
................